Situation at EU external borders – Arrivals down in first half of 2020

In the first half of this year, the number of illegal border crossings at Europe’s external borders fell by nearly a one-fifth from a year ago to 36 400*, mainly because of the effects of the COVID pandemic. The drop was especially pronounced on the Western and Eastern Mediterranean migratory routes. In June, the number […]

Working group on euro risk-free rates recommends voluntary compensation for legacy swaption contracts affected by the discounting transition to the €STR

Working group recommends voluntary compensation for legacy swaption contracts Market participants advised to contact swaption counterparties to discuss and decide on voluntary compensation No single preferred option for implementing voluntary compensation, but several potential modalities identified. The private sector working group on euro risk-free rates has today endorsed a recommendation that counterparties voluntarily exchange compensation […]

European Commission, EMA and FDA agree new priorities to strengthen their collaboration on medicines

Senior officials from the European Commission (EC – DG SANTE), EMA and the United States Food and Drug Administration (FDA) held their 2020 bilateral regulatory dialogue meeting on 18 and 19 June. During this virtual two-day meeting, the authorities reviewed their ongoing joint initiatives, discussed strategic priorities for the coming years and identified areas where […]

Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19

The International Coalition of Medicines Regulatory Authorities (ICMRA) convened a virtual meeting of regulators from around the world on 14 May 2020 to discuss high-level policy issues and regulatory requirements to respond to the ongoing COVID-19 pandemic. The strategic meeting underlined the need and commitment by global regulators to cooperate and align their approaches to […]

Chloroquine and hydroxychloroquine only to be used in clinical trials or emergency use programmes

Chloroquine and hydroxychloroquine, two medicines currently authorised for malaria and certain autoimmune diseases, are being investigated worldwide for their potential to treat coronavirus disease (COVID-19). However, efficacy in treating COVID-19 is yet to be shown in studies. It is very important that patients and healthcare professionals only use chloroquine and hydroxychloroquine for their authorised uses […]

Track legal obligations with the new EU Chemicals Legislation Finder

ECHA’s new online service, the EU Chemicals Legislation Finder (EUCLEF), gives companies access to a free-of-charge overview of 40 pieces of EU chemicals legislation they may need to comply with. With EUCLEF’s launch, information on 40 pieces of EU chemicals legislation is now easily accessible in one place, bringing clarity to companies, in particular for […]